Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.41 USD | -2.00% | -3.50% | +66.42% |
May. 08 | Design Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 07 | Piper Sandler Upgrades Design Therapeutics to Overweight From Neutral | MT |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 249M |
---|---|---|---|---|---|
Net income 2024 * | -58M | Net income 2025 * | -77M | EV / Sales 2024 * | - |
Net cash position 2024 * | 256M | Net cash position 2025 * | 198M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-4.32
x | P/E ratio 2025 * |
-3.42
x | Employees | 57 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 63.46% |
1 day | -2.00% | ||
1 week | -3.50% | ||
Current month | +25.28% | ||
1 month | +17.91% | ||
3 months | +67.68% | ||
6 months | +98.65% | ||
Current year | +66.42% |
Managers | Title | Age | Since |
---|---|---|---|
Pratik Shah
CEO | Chief Executive Officer | 54 | 17-12-17 |
Sean Jeffries
COO | Chief Operating Officer | 44 | 20-12-31 |
Jae B. Kim
CTO | Chief Tech/Sci/R&D Officer | 55 | 22-01-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Pratik Shah
CEO | Chief Executive Officer | 54 | 17-12-17 |
John Schmid
BRD | Director/Board Member | 61 | 20-10-31 |
Simeon George
BRD | Director/Board Member | 46 | 20-01-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.05% | 0 M€ | 0.00% | - | |
0.03% | 0 M€ | 0.00% | - | |
0.02% | 1,487 M€ | +9.17% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 4.41 | -2.00% | 121,302 |
24-05-16 | 4.5 | -0.22% | 112,228 |
24-05-15 | 4.51 | +0.45% | 112,878 |
24-05-14 | 4.49 | -1.32% | 125,297 |
24-05-13 | 4.55 | -0.44% | 224,015 |
Delayed Quote Nasdaq, May 17, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+66.42% | 249M | |
-0.09% | 42.12B | |
+49.62% | 42.05B | |
-4.96% | 29.18B | |
+11.18% | 26.02B | |
-21.95% | 18.9B | |
+8.61% | 13.21B | |
+24.73% | 12.17B | |
+28.31% | 12.16B | |
-6.26% | 11.42B |
- Stock Market
- Equities
- DSGN Stock